Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats
about
Plasma kallikrein-kinin system and diabetic retinopathyOxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathyVasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress.The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.Current and investigational drugs for the treatment of diabetic retinopathy.Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the ratIntraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model.Targeting the 'Janus face' of the B2-bradykinin receptor.Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.A primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of septic shock in diabetes.Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke.Localization and Interaction between Kinin B1 Receptor and NADPH Oxidase in the Vascular System of Diabetic Rats.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Kinin B1 receptors as a therapeutic target for inflammation.Expression, distribution and function of kinin B1 receptor in the rat diabetic retina.High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
P2860
Q26859982-D8627AC8-F725-404E-84A5-62D585A6CADEQ33737370-4E2F2176-5485-47C4-BADF-7F910230D80AQ34368742-82003578-053F-4DE8-AAD1-7E7906DBB18CQ35950857-2AB08A8E-2542-487D-8D1E-A0705CAAEC80Q36066049-56E0DC5A-9CE2-4BE1-AB6F-7CA28F7A0CE0Q36104687-AF0BADE3-862E-4B53-BB09-28B11259AF97Q36287115-ED4CC9AA-3189-4ABB-9CEC-C55DB385065DQ36596540-7D7A58A9-2423-417A-92FF-E5C0AE5ADA62Q37285900-76AA7538-D1D0-49B1-B395-BFA0332A94EEQ38129928-925698ED-E4A2-4A48-BC9B-676C41C3FB17Q38190099-DD66D86E-9E8E-4B36-8C5A-4E0D93910445Q38217456-1773954A-A148-4564-BB8A-A62B22D451F5Q40493046-A34454B4-B16A-4BA2-AD23-49DD5D4A97A4Q42620969-43E6AD37-731C-4AD9-9FD8-4DD329DED455Q44438022-79180ED7-656B-4E89-8AD2-B90133796B24Q45072634-34521029-8C0A-482E-8050-7E7BC8FB38E7Q47370922-3094A57A-554E-49C1-BF10-648E106B63A4Q48333986-8C1016A4-6F74-486B-8F8B-E3000201ED28Q53665301-F303B0A4-7B80-4295-9AAF-61C95B04B452
P2860
Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ocular application of the kini ...... n streptozotocin-diabetic rats
@ast
Ocular application of the kini ...... n streptozotocin-diabetic rats
@en
Ocular application of the kini ...... n streptozotocin-diabetic rats
@nl
type
label
Ocular application of the kini ...... n streptozotocin-diabetic rats
@ast
Ocular application of the kini ...... n streptozotocin-diabetic rats
@en
Ocular application of the kini ...... n streptozotocin-diabetic rats
@nl
prefLabel
Ocular application of the kini ...... n streptozotocin-diabetic rats
@ast
Ocular application of the kini ...... n streptozotocin-diabetic rats
@en
Ocular application of the kini ...... n streptozotocin-diabetic rats
@nl
P2093
P2860
P3181
P1433
P1476
Ocular application of the kini ...... n streptozotocin-diabetic rats
@en
P2093
Elvire Vaucher
Florence Dotigny
Jacques Sénécal
Mylène Pouliot
Réjean Couture
Sébastien Talbot
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0033864
P407
P577
2012-01-01T00:00:00Z